HUMANYX is a product-focused therapeutic antibody company addressing critical unmet medical needs. The management consists of successful entrepreneurs and scientists, having founded several other biopharmaceutical companies that have provided attractive returns for investors. The scientific staff has already developed the technologies and resources enabling the creation of human therapeutic antibody candidates against virtually any disease target, and has already succeeded in identifying such high potency human antibodies against targets in three disease areas.